These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3893944)

  • 21. Drug treatment of schizophrenia.
    Hollister LE
    Psychiatr Clin North Am; 1984 Sep; 7(3):435-52. PubMed ID: 6148741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine receptors and schizophrenia.
    Reynolds GP
    Biochem Soc Trans; 1996 Feb; 24(1):202-5. PubMed ID: 8674664
    [No Abstract]   [Full Text] [Related]  

  • 23. Dyskinesia. Research and treatment.
    Psychopharmacology Suppl; 1985; 2():1-230. PubMed ID: 3858798
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of parlodel on the electrical activity of the rat brain during experimental depressive syndrome].
    Iordanskaia TE; Krupina NA; Kryzhanovskiĭ GN; Orlova IN
    Biull Eksp Biol Med; 2000 Feb; 129(2):152-5. PubMed ID: 10732233
    [No Abstract]   [Full Text] [Related]  

  • 25. Tourette syndrome.
    Sandyk R; Bamford CR
    Pediatr Neurol; 1987; 3(1):63. PubMed ID: 2977279
    [No Abstract]   [Full Text] [Related]  

  • 26. [Dopamine D2 and serotonin 5HT2 receptors: functions, interactions and clinical consequences in schizophrenia].
    Guise S; Soubrouillard C; Blin O
    Encephale; 1997 Apr; 23 Spec No 2():10-6. PubMed ID: 9273300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ECT and tardive dyskinesia.
    Lerer B
    J Clin Psychiatry; 1984 Apr; 45(4):188. PubMed ID: 6715296
    [No Abstract]   [Full Text] [Related]  

  • 28. Schizophrenia: D4 receptor elevation. What does it mean?
    Seeman MV
    J Psychiatry Neurosci; 1994 May; 19(3):171-6. PubMed ID: 7913338
    [No Abstract]   [Full Text] [Related]  

  • 29. Overview of pharmacological approaches to therapy for Tourette syndrome.
    van Woert MH; Rosenbaum D; Enna SJ
    Adv Neurol; 1982; 35():369-75. PubMed ID: 6183950
    [No Abstract]   [Full Text] [Related]  

  • 30. [Electrophysiological and pharmacological analysis of L-dopa-induced dyskinesia and tardive dyskinesia (author's transl)].
    Bathien N; Rondot P; Koutlidis RM
    J Physiol (Paris); 1981 Apr; 77(1):131-41. PubMed ID: 6112268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trimipramine and dopamine receptor blockade.
    Golden RN; Miller H; Evans DL
    J Clin Psychiatry; 1989 Oct; 50(10):392-3. PubMed ID: 2793837
    [No Abstract]   [Full Text] [Related]  

  • 32. Dopamine D2-like receptors and the antidepressant response.
    Gershon AA; Vishne T; Grunhaus L
    Biol Psychiatry; 2007 Jan; 61(2):145-53. PubMed ID: 16934770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine receptor function and spontaneous orofacial dyskinesia in rats during 6-month neuroleptic treatments.
    Waddington JL; Cross AJ; Gamble SJ; Bourne RC
    Adv Biochem Psychopharmacol; 1983; 37():299-308. PubMed ID: 6138952
    [No Abstract]   [Full Text] [Related]  

  • 34. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1981 Dec; 42(12):455-7. PubMed ID: 6118358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serotonin and treatment of mental disorders. Present status and future perspectives].
    Sevcík J; Masek K
    Cas Lek Cesk; 1997 Jul; 136(14):431-3. PubMed ID: 9340186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensory phenomena in Tourette's syndrome.
    Scahill LD; Leckman JF; Marek KL
    Adv Neurol; 1995; 65():273-80. PubMed ID: 7872145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholecystokinin tetrapeptide-induced calcium mobilization in T cells of patients with panic disorder, major depression, or schizophrenia.
    Akiyoshi J; Isogawa K; Tsutsumi T; Kasturagi S; Kohno K; Furuta M; Yamamoto Y; Yamada K; Fujii I
    Biol Psychiatry; 1997 Jul; 42(2):151-4. PubMed ID: 9209734
    [No Abstract]   [Full Text] [Related]  

  • 39. Structural change in tardive dyskinesia.
    Mattes J
    Am J Psychiatry; 1977 Dec; 134(12):1448. PubMed ID: 920861
    [No Abstract]   [Full Text] [Related]  

  • 40. Movement disorders with neuroleptic drug treatment.
    Tarsy D
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.